Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Short Report

NR0B1 Frameshift Mutation in a Boy with Idiopathic Central Precocious Puberty

Shima H.a, e · Yatsuga S.f · Nakamura A.a · Sano S.a · Sasaki T.f · Katsumata N.a · Suzuki E.a · Hata K.b · Nakabayashi K.b · Momozawa Y.g · Kubo M.g · Okamura K.c · Kure S.e · Matsubara Y.d · Ogata T.h · Narumi S.a · Fukami M.a

Author affiliations

Departments of aMolecular Endocrinology, bMaternal-Fetal Biology and cSystems BioMedicine, and dInstitute Director, National Research Institute for Child Health and Development, Tokyo, eDepartment of Pediatrics, Tohoku University School of Medicine, Sendai, fDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, gCenter for Integrative Medical Sciences, RIKEN, Yokohama, and hDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan

Related Articles for ""

Sex Dev 2016;10:205-209

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Short Report

Received: July 21, 2016
Published online: September 21, 2016
Issue release date: October 2016

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2

ISSN: 1661-5425 (Print)
eISSN: 1661-5433 (Online)

For additional information: https://www.karger.com/SXD

Abstract

NR0B1 is the causative gene for X-linked adrenal hypoplasia congenita, characterized by adrenal insufficiency, hypogonadotropic hypogonadism, and infertility. We identified an NR0B1 frameshift mutation in a boy with precocious puberty who had no signs of adrenal insufficiency. Blood examination revealed elevated testosterone levels and gonadotropin hyperresponses to gonadotropin releasing hormone (GnRH) stimulation, together with normal adrenal hormone levels. GnRH analog treatment partially ameliorated his clinical features. Molecular analysis identified a p.Glu3fsAla*16 in NR0B1. These results expand the clinical manifestations of NR0B1 mutations to include central precocious puberty without adrenal insufficiency. NR0B1 mutations likely underlie androgen overproduction via GnRH-dependent and -independent mechanisms.

© 2016 S. Karger AG, Basel


References

  1. Ahmad I, Paterson WF, Lin L, Adlard P, Duncan P, et al: A novel missense mutation in DAX-1 with an unusual presentation of X-linked adrenal hypoplasia congenita. Horm Res 68:32-37 (2007).
  2. Argente J, Ozisik G, Pozo J, Teresa Munoz M, Soriano-Guillen L, Larry Jameson J: A novel single base deletion at codon 434 (1301delT) of the DAX1 gene associated with prepubertal testis enlargement. Mol Genet Metab 78:79-81 (2003).
  3. Carel JC, Leger J: Clinical practice. Precocious puberty. N Engl J Med 358:2366-77 (2008).
  4. Darcan S, Goksen D, Ozen S, Ozkinay F, Durmaz B, Lalli E: Gonadotropin-dependent precocious puberty in a patient with X-linked adrenal hypoplasia congenita caused by a novel DAX-1 mutation. Horm Res Paediatr 75:153-156 (2011).
  5. Domenice S, Latronico AC, Brito VN, Arnhold IJ, Kok F, Mendonca BB: Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. J Clin Endocrinol Metab 86:4068-4071 (2001).
  6. Durmaz E, Turkkahraman D, Berdeli A, Atan M, Karaguzel G, et al: A novel DAX-1 mutation presented with precocious puberty and hypogonadotropic hypogonadism in different members of a large pedigree. J Pediatr Endocrinol Metab 26:551-555 (2013).
  7. Izumi Y, Suzuki E, Kanzaki S, Yatsuga S, Kinjo S, et al: Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. Fertil Steril 102:1130-1136 (2014).
  8. Jeffs B, Meeks JJ, Ito M, Martinson FA, Matzuk MM, et al: Blockage of the rete testis and efferent ductules by ectopic Sertoli and Leydig cells causes infertility in Dax1-deficient male mice. Endocrinology 142:4486-4495 (2001).
  9. Katoh-Fukui Y, Igarashi M, Nagasaki K, Horikawa R, Nagai T, et al: Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of SOX9. Mol Genet Genomic Med 3:550-557 (2015).
  10. Koh JW, Kang SY, Kim GH, Yoo HW, Yu J: Central precocious puberty in a patient with X-linked adrenal hypoplasia congenita and Xp21 contiguous gene deletion syndrome. Ann Pediatr Endocrinol Metab 18:90-94 (2013).
  11. Landau Z, Hanukoglu A, Sack J, Goldstein N, Weintrob N, et al: Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations. Clin Endocrinol (Oxf) 72:448-454 (2010).
  12. Loke KY, Poh LK, Lee WW, Lai PS: A case of X-linked adrenal hypoplasia congenita, central precocious puberty and absence of the DAX-1 gene: implications for pubertal regulation. Horm Res 71:298-304 (2009).
  13. Macedo DB, Silveira LF, Bessa DS, Brito VN, Latronico AC: Sexual precocity-genetic bases of central precocious puberty and autonomous gonadal activation. Endocr Dev 29:50-71 (2016).
  14. O'Shaughnessy PJ, Fleming LM, Jackson G, Hochgeschwender U, Reed P, Baker PJ: Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology 144:3279-3284 (2003).
  15. Ozisik G, Mantovani G, Achermann JC, Persani L, Spada A, et al: An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 88:417-423 (2003).
  16. Seminara SB, Achermann JC, Genel M, Jameson JL, Crowley WF Jr: X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 84:4501-4509 (1999).
  17. Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC: DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab 29:607-619 (2015).
  18. Takahashi T, Shoji Y, Shoji Y, Haraguchi N, Takahashi I, Takada G: Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita. J Pediatr 130:485-488 (1997).
  19. Takahashi I, Takahashi T, Shoji Y, Takada G: Prolonged activation of the hypothalamus-pituitary-gonadal axis in a child with X-linked adrenal hypoplasia congenital. Clin Endocrinol (Oxf) 53:127-129 (2000).
  20. Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A: Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116:1323-1328 (2005).
  21. Yeste D, Gonzalez-Nino C, Perez de Nanclares G, Perez-Nanclares G, Audi L, et al: ACTH-dependent precocious pseudopuberty in an infant with DAX1 gene mutation. Eur J Pediatr 168:65-69 (2009).

Article / Publication Details

First-Page Preview
Abstract of Short Report

Received: July 21, 2016
Published online: September 21, 2016
Issue release date: October 2016

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2

ISSN: 1661-5425 (Print)
eISSN: 1661-5433 (Online)

For additional information: https://www.karger.com/SXD


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.